Differences Between Antiamyloid Therapies Lecanemab and Donanemab: Martin Sadowski, MD, PhD
November 13th 2023The professor of neurology, psychiatry, and pharmacology at the NYU Grossman School of Medicine commented on the differences in mechanisms and clinical trial data between lecanemab and donanemab. [WATCH TIME: 5 minutes]